Periodic Reporting for period 1 - Prometeo (Complete Automatization of Tissue Microarray Systems: Unleashing High-Throughput in Pathology Diagnosis, Prognosis and Anticancer Therapy)

Precision medicine is the new goal of cancer testing. Patients, pathologists and researchers need accurate, reliable and cost-effective instruments to meet the demands of the research of new diagnostic and prognostic markers. Tissue Microarray (TMA) systems can facilitate the...